269 related articles for article (PubMed ID: 26830411)
1. Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients.
Yuce-Artun N; Baskak B; Ozel-Kizil ET; Ozdemir H; Uckun Z; Devrimci-Ozguven H; Suzen HS
Int J Clin Pharm; 2016 Apr; 38(2):388-94. PubMed ID: 26830411
[TBL] [Abstract][Full Text] [Related]
2. Effect of Polymorphisms on the Pharmacokinetics, Pharmacodynamics and Safety of Sertraline in Healthy Volunteers.
Saiz-Rodríguez M; Belmonte C; Román M; Ochoa D; Koller D; Talegón M; Ovejero-Benito MC; López-Rodríguez R; Cabaleiro T; Abad-Santos F
Basic Clin Pharmacol Toxicol; 2018 May; 122(5):501-511. PubMed ID: 29136336
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of sertraline and N-desmethyl sertraline in relation to CYP2C19 genotype in psychiatric patients.
Rudberg I; Hermann M; Refsum H; Molden E
Eur J Clin Pharmacol; 2008 Dec; 64(12):1181-8. PubMed ID: 18677622
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic Influence on Stereoselective Steady-State Disposition of Bupropion.
Kharasch ED; Lenze EJ
Drug Metab Dispos; 2024 Apr; 52(5):455-466. PubMed ID: 38467432
[TBL] [Abstract][Full Text] [Related]
5. Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population.
Bråten LS; Ingelman-Sundberg M; Jukic MM; Molden E; Kringen MK
Clin Transl Sci; 2022 Sep; 15(9):2135-2145. PubMed ID: 35668575
[TBL] [Abstract][Full Text] [Related]
6. Nonresponse to high-dose bupropion for depression in a patient carrying
Stäuble CK; Lampert ML; Mikoteit T; Hatzinger M; Hersberger KE; Meyer Zu Schwabedissen HE
Pharmacogenomics; 2020 Nov; 21(16):1145-1150. PubMed ID: 33124517
[TBL] [Abstract][Full Text] [Related]
7. The impact of CYP2C19 polymorphisms on citalopram metabolism in patients with major depressive disorder.
Uckun Z; Baskak B; Ozel-Kizil ET; Ozdemir H; Devrimci Ozguven H; Suzen HS
J Clin Pharm Ther; 2015 Dec; 40(6):672-9. PubMed ID: 26343256
[TBL] [Abstract][Full Text] [Related]
8. Allele and Genotype Frequencies of Cytochrome P450 2B6 516G>T Single Nucleotide Polymorphism in HIV-Negative and HIV-Infected Adult Nigerian Populations.
Saʼad Toyin A; Julius Olugbenga S; Rahman Ayodele B; Olusola Joseph O; Taibat Moji BO
Am J Ther; 2016; 23(6):e1715-e1719. PubMed ID: 26938766
[TBL] [Abstract][Full Text] [Related]
9. Allele and genotype frequencies of CYP2B6 and CYP2C19 polymorphisms in Egyptian agricultural workers.
Ellison CA; Abou El-Ella SS; Tawfik M; Lein PJ; Olson JR
J Toxicol Environ Health A; 2012; 75(4):232-41. PubMed ID: 22352331
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial pharmacogenomic algorithm is predictive of sertraline metabolism in patients with major depressive disorder.
Parikh SV; Law RA; Hain DT; Rothschild AJ; Thase ME; Dunlop BW; DeBattista C; Forester BP; Shelton RC; Macaluso M; Cogan ES; Brown K; Lewis DJ; Jablonski MR; Greden JF
Psychiatry Res; 2022 Feb; 308():114354. PubMed ID: 34986431
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic Assessment of Drug Metabolic Pathways and P-Glycoprotein in Patients Treated With Antidepressants in an Ambulatory Setting.
Lloret-Linares C; Bosilkovska M; Daali Y; Gex-Fabry M; Heron K; Bancila V; Michalopoulos G; Perroud N; Richard-Lepouriel H; Aubry JM; Desmeules J; Besson M
J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29570971
[TBL] [Abstract][Full Text] [Related]
12. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.
Bousman CA; Stevenson JM; Ramsey LB; Sangkuhl K; Hicks JK; Strawn JR; Singh AB; Ruaño G; Mueller DJ; Tsermpini EE; Brown JT; Bell GC; Leeder JS; Gaedigk A; Scott SA; Klein TE; Caudle KE; Bishop JR
Clin Pharmacol Ther; 2023 Jul; 114(1):51-68. PubMed ID: 37032427
[TBL] [Abstract][Full Text] [Related]
13. Effects of CYP3A5, CYP2C19, and CYP2B6 on the clinical efficacy and adverse outcomes of sibutramine therapy: a crucial role for the CYP2B6*6 allele.
Hwang IC; Park JY; Ahn HY; Kim KK; Suh HS; Ko KD; Kim KA
Clin Chim Acta; 2014 Jan; 428():77-81. PubMed ID: 24262967
[TBL] [Abstract][Full Text] [Related]
14. Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients.
Bråten LS; Haslemo T; Jukic MM; Ingelman-Sundberg M; Molden E; Kringen MK
Neuropsychopharmacology; 2020 Feb; 45(3):570-576. PubMed ID: 31649299
[TBL] [Abstract][Full Text] [Related]
15. Genetic markers in CYP2C19 and CYP2B6 for prediction of cyclophosphamide's 4-hydroxylation, efficacy and side effects in Chinese patients with systemic lupus erythematosus.
Shu W; Guan S; Yang X; Liang L; Li J; Chen Z; Zhang Y; Chen L; Wang X; Huang M
Br J Clin Pharmacol; 2016 Feb; 81(2):327-40. PubMed ID: 26456622
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 Genetic Variations Can Predict mRNA Expression, Cyclophosphamide 4-Hydroxylation, and Treatment Outcomes in Chinese Patients With Non-Hodgkin's Lymphoma.
Shu W; Chen L; Hu X; Zhang M; Chen W; Ma L; Liu X; Huang J; Pang T; Li J; Zhang Y
J Clin Pharmacol; 2017 Jul; 57(7):886-898. PubMed ID: 28181240
[TBL] [Abstract][Full Text] [Related]
17. Effect of CYP2C19 polymorphisms on antidepressant prescription patterns and treatment emergent mania in bipolar disorder.
Joas E; Jonsson L; Viktorin A; Smedler E; Pålsson E; Goodwin GM; Landén M
Pharmacogenomics J; 2023 Jan; 23(1):28-35. PubMed ID: 36333412
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of Sertraline Tolerability and Response in Pediatric Anxiety and Depressive Disorders.
Poweleit EA; Aldrich SL; Martin LJ; Hahn D; Strawn JR; Ramsey LB
J Child Adolesc Psychopharmacol; 2019 Jun; 29(5):348-361. PubMed ID: 31066578
[No Abstract] [Full Text] [Related]
19. Cytochrome P450 polymorphisms and the response of lupus nephritis to cyclophosphamide therapy.
Winoto J; Song H; Hines C; Nagaraja H; Rovin BH
Clin Nephrol; 2011 May; 75(5):451-7. PubMed ID: 21543025
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 CYP2B6*6 distribution among Congolese individuals with HIV, Tuberculosis and Malaria infection.
Peko SM; Gueye NSG; Vouvoungui C; Koukouikila-Koussounda F; Kobawila SC; Nderu D; Velavan TP; Ntoumi F
Int J Infect Dis; 2019 May; 82():111-116. PubMed ID: 30818046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
